By Associate Professor Yael Barnett

Journal articles

Kyle K; Peters J; Jonker B; Barnett Y; Maamary J; Barnett M; Maller J; Wang C; Tisch S, 2024, 'Magnetic Resonance–Guided Focused Ultrasound for Treatment of Essential Tremor: Ventral Intermediate Nucleus Ablation Alone or Additional Posterior Subthalamic Area Lesioning?', Movement Disorders Clinical Practice, 11, pp. 504 - 514, http://dx.doi.org/10.1002/mdc3.14005

Peters J; Maamary J; Kyle K; Olsen N; Jones L; Bolitho S; Barnett Y; Jonker B; Tisch S, 2024, 'Reply to: Recurrence of Parkinson's Disease Tremor after Focused Ultrasound Thalamotomy?', Movement Disorders, 39, pp. 759 - 760, http://dx.doi.org/10.1002/mds.29756

Kyle K; Maamary J; Jonker B; Peters J; Barnett Y; Barnett M; D’Souza A; Maller J; Wang C; Tisch S, 2024, 'Consistency is key: influence of skull density ratio distribution on the formation of clinically effective lesions and long-term tremor suppression following treatment with MR-guided focused ultrasound', Journal of Neurosurgery, 140, pp. 648 - 656, http://dx.doi.org/10.3171/2023.6.JNS231153

Peters J; Maamary J; Kyle K; Olsen N; Jones L; Bolitho S; Barnett Y; Jonker B; Tisch S, 2024, 'Reply to: “Focused Ultrasound Thalamotomy in Dystonic Tremor—Favourable Outcomes with VIM Lesioning Alone”', Movement Disorders, 39, pp. 453 - 454, http://dx.doi.org/10.1002/mds.29711

Peters J; Maamary J; Kyle K; Olsen N; Jones L; Bolitho S; Barnett Y; Jonker B; Tisch S, 2024, 'Outcomes of Focused Ultrasound Thalamotomy in Tremor Syndromes', Movement Disorders, 39, pp. 173 - 182, http://dx.doi.org/10.1002/mds.29658

Barnett M; Wang D; Beadnall H; Bischof A; Brunacci D; Butzkueven H; Brown JWL; Cabezas M; Das T; Dugal T; Guilfoyle D; Klistorner A; Krieger S; Kyle K; Ly L; Masters L; Shieh A; Tang Z; van der Walt A; Ward K; Wiendl H; Zhan G; Zivadinov R; Barnett Y; Wang C, 2023, 'A real-world clinical validation for AI-based MRI monitoring in multiple sclerosis', npj Digital Medicine, 6, http://dx.doi.org/10.1038/s41746-023-00940-6

Maamary J; Peters J; Kyle K; Ruge D; Jonker B; Barnett Y; Tisch S, 2023, 'Evaluation of the efficacy and safety of MRI-guided focused ultrasound (MRgFUS) for focal hand dystonia: study protocol for an open-label non-randomised clinical trial', BMJ Neurology Open, 5, http://dx.doi.org/10.1136/bmjno-2023-000522

Petzold A; Liu Y; Fraser C; Abegg M; Alroughani R; Alshowaeir D; Alvarenga R; Andris C; Asgari N; Barnett Y; Battistella R; Behbehani R; Berger T; Bikbov MM; Biotti D; Biousse V; Boschi A; Brazdil M; Brezhnev A; Calabresi P; Cordonnier M; Costello F; Cruz FM; Cunha LP; Daoudi S; Deschamps R; DeSeze J; Diem R; Etemadifar M; Flores-Rivera J; Fonseca P; Frederiksen J; Frohman E; Frohman T; FromentTilikete C; Fujihara K; Gálvez A; Gouider R; Gracia F; Grigoriadis N; Guajardo JM; Habek M; Hawlina M; Hernández-Martínez de Lapiscina E; Hooker J; Hor JY; Howlett W; Huang-Link Y; Idrissova Z; Illes Z; Jancic J; Jindahra P; Karussis D; Kerty E; Kim HJ; Lagrèze W; Leocani L; Levin N; Liskova P; Maiga Y; Marignier R; McGuigan C; Meira D; Merle H; Monteiro MLR; Moodley A; Moura F; Muñoz S; Mustafa S; Nakashima I; Noval S; Oehninger C; Ogun O; Omoti A; Pandit L; Paul F; Rebolleda G; Reddel S; Rejdak K; Rejdak R; Rodriguez-Morales A; Rougier MB; Sa MJ; Sanchez-Dalmau B; Saylor D; Shatriah I; Siva A; Stiebel-Kalish H; Szatmary G; Ta L; Tenembaum S; Tran H; Trufanov Y; VanPesch V; Wang AG; Wattjes MP; Willoughby E; Zakaria M; Zvornicanin J; Balcer L, 2023, 'Application of diagnostic criteria for optic neuritis – Authors' reply', The Lancet Neurology, 22, pp. 376 - 377, http://dx.doi.org/10.1016/S1474-4422(23)00110-2

Maamary J; Peters J; Kyle K; Barnett Y; Jonker B; Tisch S, 2023, 'Effective Subthalamic Nucleus Deep Brain Stimulation Following MRgFUS for Tremor Dominant Parkinson's Disease', Movement Disorders Clinical Practice, 10, pp. 486 - 492, http://dx.doi.org/10.1002/mdc3.13662

Maamary J; Maddocks S; Barnett Y; Wong S; Rodriguez M; Hueston L; Jeoffreys N; Eden JS; Dwyer DE; Floyd T; Plit M; Kok J; Brew B, 2023, 'New Detection of Locally Acquired Japanese Encephalitis Virus Using Clinical Metagenomics, New South Wales, Australia', Emerging Infectious Diseases, 29, pp. 627 - 630, http://dx.doi.org/10.3201/eid2903.220632

Wang D; Jin R; Shieh CC; Ng AY; Pham H; Dugal T; Barnett M; Winoto L; Wang C; Barnett Y, 2023, 'Real world validation of an AI-based CT hemorrhage detection tool', Frontiers in Neurology, 14, http://dx.doi.org/10.3389/fneur.2023.1177723

Kyle K; Maller J; Barnett Y; Jonker B; Barnett M; D’Souza A; Calamante F; Maamary J; Peters J; Wang C; Tisch S, 2023, 'Tremor supression following treatment with MRgFUS: skull density ratio consistency and degree of posterior dentatorubrothalamic tract lesioning predicts long-term clinical outcomes in essential tremor', Frontiers in Neurology, 14, http://dx.doi.org/10.3389/fneur.2023.1129430

Petzold A; Fraser CL; Abegg M; Alroughani R; Alshowaeir D; Alvarenga R; Andris C; Asgari N; Barnett Y; Battistella R; Behbehani R; Berger T; Bikbov MM; Biotti D; Biousse V; Boschi A; Brazdil M; Brezhnev A; Calabresi PA; Cordonnier M; Costello F; Cruz FM; Cunha LP; Daoudi S; Deschamps R; de Seze J; Diem R; Etemadifar M; Flores-Rivera J; Fonseca P; Frederiksen J; Frohman E; Frohman T; Tilikete CF; Fujihara K; Gálvez A; Gouider R; Gracia F; Grigoriadis N; Guajardo JM; Habek M; Hawlina M; Martínez-Lapiscina EH; Hooker J; Hor JY; Howlett W; Huang-Link Y; Idrissova Z; Illes Z; Jancic J; Jindahra P; Karussis D; Kerty E; Kim HJ; Lagrèze W; Leocani L; Levin N; Liskova P; Liu Y; Maiga Y; Marignier R; McGuigan C; Meira D; Merle H; Monteiro MLR; Moodley A; Moura F; Muñoz S; Mustafa S; Nakashima I; Noval S; Oehninger C; Ogun O; Omoti A; Pandit L; Paul F; Rebolleda G; Reddel S; Rejdak K; Rejdak R; Rodriguez-Morales AJ; Rougier MB; Sa MJ; Sanchez-Dalmau B; Saylor D; Shatriah I; Siva A; Stiebel-Kalish H; Szatmary G; Ta L; Tenembaum S; Tran H; Trufanov Y; van Pesch V; Wang AG; Wattjes MP; Willoughby E; Zakaria M; Zvornicanin J; Balcer L, 2022, 'Diagnosis and classification of optic neuritis', The Lancet Neurology, 21, pp. 1120 - 1134, http://dx.doi.org/10.1016/S1474-4422(22)00200-9

Law LY; Barnett MH; Barnett Y; Masters L; Beadnall HN; Hardy TA; Reddel SW, 2022, 'Presumptive isolated neurosarcoidosis involving eloquent structures: An argument for empirical TNF-α inhibition', Journal of Neuroimmunology, 372, http://dx.doi.org/10.1016/j.jneuroim.2022.577956

Barnett M; Barnett Y; Reddel S, 2022, 'MRI and laboratory monitoring of disease-modifying therapy efficacy and risks', Current Opinion in Neurology, 35, pp. 278 - 285, http://dx.doi.org/10.1097/WCO.0000000000001067

Chatterton S; Dwyer L; Thomson C; Plit M; Longmuir H; Chaganti J; Barnett Y; Brew B, 2022, 'Atypical presentations and course of JC virus infection', Journal of NeuroVirology, 28, pp. 183 - 186, http://dx.doi.org/10.1007/s13365-021-01031-6

Wang C; Barton J; Kyle K; Ly L; Barnett Y; Hartung HP; Reddel SW; Beadnall H; Taha M; Klistorner A; Barnett MH, 2021, 'Multiple sclerosis: Structural and functional integrity of the visual system following alemtuzumab therapy', Journal of Neurology, Neurosurgery and Psychiatry, 92, pp. 1319 - 1324, http://dx.doi.org/10.1136/jnnp-2021-326164

Wilson DN; Barnett Y; Kyle K; Tisch S; Jonker BP, 2021, 'Predictors of thermal response and lesion size in patients undergoing magnetic resonance-guided focused ultrasound thalamotomy', Journal of Clinical Neuroscience, 91, pp. 75 - 79, http://dx.doi.org/10.1016/j.jocn.2021.06.019

Baskin J; Hardy TA; Law LY; Bolitho S; Barnett Y, 2021, 'Black blood MRI: endotheliopathy of Susac syndrome unmasked', Neurological Sciences, 42, pp. 325 - 327, http://dx.doi.org/10.1007/s10072-020-04562-8

Leaney JC; Nguyen V; Miranda E; Barnett Y; Ahmad K; Wong S; Lawlor M, 2020, 'Bruch's Membrane Opening Minimum Rim Width Provides Objective Differentiation between Glaucoma and Nonglaucomatous Optic Neuropathies', American Journal of Ophthalmology, 218, pp. 164 - 172, http://dx.doi.org/10.1016/j.ajo.2020.05.034

Barnett Y; Garber JY; Barnett MH, 2020, 'MRI biomarkers of disease progression in multiple sclerosis: Old dog, new tricks?', Quantitative Imaging in Medicine and Surgery, 10, pp. 527 - 532, http://dx.doi.org/10.21037/qims.2020.01.04

Massey J; Barnett Y; Curnow J; Sutton I, 2019, 'B cell depletion therapy resulting in sustained remission of severe autoimmune complications following Alemtuzumab treatment of Multiple Sclerosis', Multiple Sclerosis and Related Disorders, 35, pp. 100 - 103, http://dx.doi.org/10.1016/j.msard.2019.07.016

Wang CT; Barnett M; Barnett Y, 2019, 'Imaging the multiple sclerosis lesion: Insights into pathogenesis, progression and repair', Current Opinion in Neurology, 32, pp. 338 - 345, http://dx.doi.org/10.1097/WCO.0000000000000698

Moore JJ; Massey JC; Ford CD; Khoo ML; Zaunders JJ; Hendrawan K; Barnett Y; Barnett MH; Kyle KA; Zivadinov R; Ma KC; Milliken ST; Sutton IJ; Ma DDF, 2019, 'Prospective phase II clinical trial of autologous haematopoietic stem cell transplant for treatment refractory multiple sclerosis', Journal of Neurology, Neurosurgery and Psychiatry, 90, pp. 514 - 521, http://dx.doi.org/10.1136/jnnp-2018-319446

Van Hecke W; Ribbens A; Billiet T; Zivadinov R; Ramasamy DP; Dwyer MG; Bergsland N; Carl E; Wang C; Ly L; Barnett Y; Masters L; Barnett MH; Beadnall HN, 2019, 'New/Enlarging Lesion Count: Man versus Machine (P5.2-027)', Neurology, 92, http://dx.doi.org/10.1212/wnl.92.15_supplement.p5.2-027

Giarola B; Massey J; Barnett Y; Rodrigues M; Sutton I, 2019, 'Autoimmune encephalitis following alemtuzumab treatment of multiple sclerosis', Multiple Sclerosis and Related Disorders, 28, pp. 31 - 33, http://dx.doi.org/10.1016/j.msard.2018.12.004

Triplett J; Rigney L; Hardy TA; Barnett Y; Hayes MW; Barnett M; Reddel SW, 2019, 'Forearm-predominant parainfectious myositis', Muscle and Nerve, 59, pp. E7 - E10, http://dx.doi.org/10.1002/mus.26367

Beadnall H; Barnett Y; Ly L; Wang C; Billiet T; Ribbens A; Hecke WV; Masters L; Hardy TA; Barnett MH, 2018, '005 Filling in the gaps: precision MRI reporting in multiple sclerosis clinical practice', Journal of Neurology, Neurosurgery & Psychiatry, 89, pp. A3.2 - A4, http://dx.doi.org/10.1136/jnnp-2018-anzan.5

Barton J; Hardy TA; Riminton S; Reddel SW; Barnett Y; Coles A; Barnett MH, 2017, 'Tumefactive demyelination following treatment for relapsing multiple sclerosis with alemtuzumab', Neurology, 88, pp. 1004 - 1006, http://dx.doi.org/10.1212/WNL.0000000000003694

Hardy TA; Wang C; Beadnall HN; Lagopoulos J; Barnett Y; Klistorner A; Barnett MH, 2016, 'Wallerian Degeneration in the Corticospinal Tract Following Tumefactive Demyelination: Conventional and Advanced Magnetic Resonance Imaging', Canadian Journal of Neurological Sciences, 43, pp. 726 - 727, http://dx.doi.org/10.1017/cjn.2016.253

Samadi B; Nguyen D; Rudham S; Barnett Y, 2016, 'Spinal Cord Infarct during Concomitant Circulatory Support with Intra-Aortic Balloon Pump and Veno-Arterial Extracorporeal Membrane Oxygenation', Critical Care Medicine, 44, pp. e101 - e105, http://dx.doi.org/10.1097/CCM.0000000000001400

Massey J; Buckland ME; Barnett Y; Sutton I, 2016, 'Expanding the range of immunopathology in neuromyelitis optica spectrum disorder', BMJ Case Reports, 2016, http://dx.doi.org/10.1136/bcr-2016-215981

Garg N; Reddel SW; Miller DH; Chataway J; Riminton DS; Barnett Y; Masters L; Barnett MH; Hardy TA, 2015, 'The corpus callosum in the diagnosis of multiple sclerosis and other CNS demyelinating and inflammatory diseases', Journal of Neurology, Neurosurgery and Psychiatry, 86, pp. 1374 - 1382, http://dx.doi.org/10.1136/jnnp-2014-309649

Barnett Y; Sutton IJ; Ghadiri M; Masters L; Zivadinov R; Barnett MH, 2014, 'Conventional and advanced imaging in neuromyelitis optica', American Journal of Neuroradiology, 35, pp. 1458 - 1466, http://dx.doi.org/10.3174/ajnr.A3592

Ghadiri M; Buckland ME; Sutton IJ; Al Jahdhami S; Flanagan S; Heard R; Barnett Y; Brennan J; Barnett MH, 2014, 'Progressive neuropsychiatric symptoms and motor impairment', JAMA Neurology, 71, pp. 794 - 798, http://dx.doi.org/10.1001/jamaneurol.2013.6308

Geevasinga N; Cole C; Herkes GK; Barnett Y; Lin J; Needham M, 2014, 'Sickle cell disease and posterior reversible leukoencephalopathy', Journal of Clinical Neuroscience, 21, pp. 1329 - 1332, http://dx.doi.org/10.1016/j.jocn.2013.10.028

Hurelbrink CB; Barnett Y; Buckland ME; Wilkinson M; Leicester J; Anderson C; Brennan J; Barnett M, 2012, 'Revisiting cerebral thromboangiitis obliterans', Journal of the Neurological Sciences, 317, pp. 141 - 145, http://dx.doi.org/10.1016/j.jns.2012.03.011

Chohan G; Barnett Y; Gibson J; Reddel SWR; Barnett MH, 2012, 'Langerhans cell histiocytosis with refractory central nervous system involvement responsive to infliximab', Journal of Neurology, Neurosurgery and Psychiatry, 83, pp. 573 - 575, http://dx.doi.org/10.1136/jnnp-2011-300575

Barnett MH; Barnett Y; Burke D; Willison H, 2011, 'Spinal nerve root hypertrophy in chronic ataxic neuropathy with antiglycolipid IgM antibodies', Journal of Neurology, Neurosurgery and Psychiatry, 82, pp. 97, http://dx.doi.org/10.1136/jnnp.2010.205096

Back to profile page